Amsacrine
Amsacrine Basic information
- Product Name:
- Amsacrine
- Synonyms:
-
- M-AMSA, HCL
- M-AMSA HYDROCHLORIDE
- N-[4-(Acridin-9-ylamino)-3-(methyloxy)phenyl]methanesulfonamide
- Amekrin
- Amsakrin
- Amsidyl
- CI-880
- 4'-(9-Acridinylamino)methanesulfon-m-anisidide
- CAS:
- 51264-14-3
- MF:
- C21H19N3O3S
- MW:
- 393.46
- EINECS:
- 257-094-3
- Product Categories:
-
- Pharmaceutical material and intermeidates
- Mol File:
- 51264-14-3.mol
Amsacrine Chemical Properties
- Melting point:
- 230-240 °C
- Boiling point:
- 563.0±60.0 °C(Predicted)
- Density
- 1.2205 (rough estimate)
- refractive index
- 1.6740 (estimate)
- storage temp.
- 2-8°C(protect from light)
- solubility
- Soluble in DMSO
- form
- Powder
- pka
- 8.55±0.10(Predicted)
- color
- Orange to red
- CAS DataBase Reference
- 51264-14-3
- IARC
- 2B (Vol. 76) 2000
Safety Information
- RIDADR
- 3249
- HazardClass
- 6.1(b)
- PackingGroup
- III
- Hazardous Substances Data
- 51264-14-3(Hazardous Substances Data)
- Toxicity
- LD50 in male, female CDF1 mice: 810 mg/m2; 729 mg/m2 orally (Pavkov)
Amsacrine Usage And Synthesis
Description
Amsacrine is a cytostatic reported to be active against adult lymphoblastic leukemia which has failed primary treatment or become resistant. Its clinical use, however, is associated with significant neuro-, gastro- and hepatotoxicity.
Originator
Auckland Cancer Chemotherapy Lab (New Zealand)
Uses
Amsacrine (Amsidyl) is used as an Investigational drug.
Uses
Amsacrine is a drug undergoing intensive trials for severe leukemia and lymphoma. It is a cytotoxic drug that binds with DNA with expressed specificity to the adenosine–tyrosine pair, thus inhibiting DNA synthesis. It has been suggested to be used for severe leukemia. A synonym of this drug is amsidyl.
Uses
Antineoplastic.
Definition
ChEBI: A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
brand name
Amsidyl (Parke-Davis);Amsakrin.
Synthesis
Amsacrine, 4-(9-acridinylamino)-3-methoxyphenyl-N-methansulfonamide (30.6.11), is made by sulfonating 4-nitro-m-anisidine with methanesulfonyl chloride, which forms a sulfonyl amide 30.6.9, and the nitro group is reduced to an amino group by hydrogen, forming 4-amino-3-methoxyphenyl-N-methansulfonamide (30.6.10). Reacting this with 9-chloroacridine gives amsacrine (30.6.11).
References
[1] nelson em, tewey km, liu lf. mechanism of antitumor drug action: poisoning of mammalian dna topoisomerase ii on dna by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. proc natl acad sci u s a. 1984 mar;81(5):1361-5.
Amsacrine Preparation Products And Raw materials
Raw materials
AmsacrineSupplier
- Tel
- 0573-85285100 18627885956
- isenchem@163.com
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
- Tel
- 15527768850
- 1791901229@qq.com
- Tel
- 010-56205725
- waley188@sohu.com
- Tel
- 025-66099280 17798518460
- cfzhang@aikonchem.com
Amsacrine(51264-14-3)Related Product Information
- 2-ETHOXY-6,9-DIAMINOACRIDINE
- Sulfanilamide
- Quinacridone
- 9(10H)-ACRIDONE
- m-Phenylenediamine
- 4-Methoxyphenylacetone
- 6,9-DIAMINO-2-ETHOXYACRIDINE LACTATE
- PHENYL VALERATE
- Tamoxifen
- Basic Orange 14
- 3-Aminobenzenesulfonamide
- p-Phenylenediamine
- o-Phenylenediamine
- Phenylacetic acid
- Phenylpropanolamine
- Amsacrine hydrochloride
- CI 921
- Amsacrine